| Literature DB >> 29125539 |
Marica Grossegesse1, Joerg Doellinger2,3, Alona Tyshaieva4, Lars Schaade5, Andreas Nitsche6.
Abstract
DNA viruses, like poxviruses, possess a highly stable genome, suggesting that adaptation of virus particles to specific cell types is not restricted to genomic changes. Cowpox viruses are zoonotic poxviruses with an extraordinarily broad host range, demonstrating their adaptive potential in vivo. To elucidate adaptation mechanisms of poxviruses, we isolated cowpox virus particles from a rat and passaged them five times in a human and a rat cell line. Subsequently, we analyzed the proteome and genome of the non-passaged virions and each passage. While the overall viral genome sequence was stable during passaging, proteomics revealed multiple changes in the virion composition. Interestingly, an increased viral fitness in human cells was observed in the presence of increased immunomodulatory protein amounts. As the only minor variant with increasing frequency during passaging was located in a viral RNA polymerase subunit and, moreover, most minor variants were found in transcription-associated genes, protein amounts were presumably regulated at transcription level. This study is the first comparative proteome analysis of virus particles before and after cell culture propagation, revealing proteomic changes as a novel poxvirus adaptation mechanism.Entities:
Keywords: adaptation; cell culture; cowpox virus; genomics; passaging; poxvirus; proteomics
Mesh:
Substances:
Year: 2017 PMID: 29125539 PMCID: PMC5707544 DOI: 10.3390/v9110337
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Virus yield during CPXV crust passaging reveals a replication gain in human cells. Viral genome equivalents (GE) of passaged CPXV crust were determined by qPCR after cell lysis. Shown are mean values ± standard deviation (SD) of normalized virus yield. Statistics: One-way analysis of variance and Bonferroni’s multiple comparisons test (* p ≤ 0.05).
Figure 2Real-time cell analysis of HEp-2 and Rat-2 cells infected with CPXV crust and passages reveals no differences among passages but heterogeneities of the crust. (a) HEp-2 and (b) Rat-2 cells were seeded in 96-well E-plates and cell adherence was measured over time. About 24 h after seeding, cells were infected with purified CPXV originating from a rat crust or from different passages (P1–P5) at an MOI of 0.1 (arrow). Shown are mean values ± SD of biological triplicates of passages measured in technical quadruplicates (n = 12) or six technical replicates of the crust, which cluster in two different courses (crust_I and II) with each n = 3. NTC: non-infected cells.
Mutations in coding sequences during CPXV crust passaging.
| CDS a | Pos. b | Nucleotide Change | PE c | Amino Acid Change | Variant Frequency HEp-2 | Variant Frequency Rat-2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P0 | P1 | P2 | P3 | P4 | P5 | P1 | P2 | P3 | P4 | P5 | |||||
| 728 | A→G | S | K→R | 1.2 | |||||||||||
| 1149 | (A)8→(A)9 | FS | none | 1.4 | |||||||||||
| 269 | A→C | S | K→T | 3.1 | 2.7 | 4.2 | 6.4 | 2.9 | 11.4 | 2.2 | 4.2 | 2.7 | 9.5 | 4.6 | |
| 4 | (A)8→(A)9 | FS | 1.3 | 1.4 | |||||||||||
| 1091 | G→T | S | H→Q | 1.1 | |||||||||||
| 1118 | (GTT)8→(GTT)9 | I | P→QP | 3.1 | 2.7 | 2.9 | 2.6 | 3.4 | 2.6 | 4.2 | 2.5 | ||||
| 1115 | (GTT)8→(GTT)7 | D | QP→P | 4.6 | 4.3 | 3.8 | 3.8 | 4.2 | 4.6 | ||||||
| 1093 | (TTG)8→(TTG)7 | D | Q→ | 3.7 | 5.0 | 3.4 | |||||||||
| 1093 | (TTG)8→(TTG)9 | I | →Q | 4.0 | 2.6 | 2.8 | |||||||||
| 259 | (A)8→(A)9 | FS | 1.5 | ||||||||||||
| 465 | C→A | S | R→S | 1.2 | |||||||||||
| 168 | C→T | N | none | 1.5 | |||||||||||
| 613 | ATA→TCC | S | Y→G | 1.9 | |||||||||||
| 615 | A→T | T | 1.0 | 1.1 | |||||||||||
| 616 | +TCC | I | →G | 8.8 | 7.4 | ||||||||||
| 611 | C→T | S | S→N | 8.7 | 7.4 | ||||||||||
| 606 | G→A | N | none | 8.5 | 7.1 | ||||||||||
| 474 | (T)7→(T)8 | FS | 2.9 | 2.0 | 1.7 | 2.2 | |||||||||
| 481 | (T)7→(T)8 | FS | 2.6 | ||||||||||||
| 716 | A→T | S | E→V | 1.8 | |||||||||||
| 28 | A→G | S | N→D | 1.3 | |||||||||||
| 101 | +GG | FS | 1.1 | ||||||||||||
| 319 | A→G | S | K→E | 2.1 | |||||||||||
| 1084 | (T)10→(T)11 | FS | 1.9 | ||||||||||||
| 1648 | T→C | S | S→P | 1.1 | |||||||||||
Variant frequencies are shown in %; P0: crust; a Coding sequence (CDS; gene name according to CPXV GRI-90); b Position (Pos.) in gene; c Protein effect, S: Substitution, FS: Frame Shift, I: Insertion, D: Deletion, T: Truncation, N: None.
Figure 3Principal component analysis and hierarchical clustering of CPXV IMV proteins reveal proteomic differences among passages. Normalized label-free quantification (LFQ) intensities of virus proteins without missing values were used for (a) principal component analysis prior to z-score normalization and (b) hierarchical clustering after z-score normalization.
Figure 4Viral proteins changing in an adaptation-associated manner during passaging in HEp-2 and Rat 2 cells. Proteins are sorted according to adaptation-associated time courses with distances ≤0.1 to reference profiles A–D, which are shown in Figure S1. (a) A single viral protein (G13) displays comparable courses during passaging in both cell lines (cell line unspecific). Proteins changing in a cell-line-independent manner were identified in (b) Rat-2- and (c) HEp-2-passaged virions. Shown are normalized LFQ intensities (log2) of ANOVA-significant proteins. Error bars indicate means ± SD of three biological replicates (passages 1–5) or three technical replicates (passage 0: crust).
Function of viral proteins changing in a cell type-specific manner during passaging.
| Protein | Description a | Function |
|---|---|---|
| HEp-2 | ||
| A34 | EEV glycoprotein | membrane |
| E8 | Cell-surface-binding protein | membrane |
| E13 | Scaffold protein | membrane |
| B17 | Soluble IFN-α/β receptor | immune evasion |
| C17 | Complement control protein | immune evasion |
| D1/I5 | Secreted chemokine-binding protein | immune evasion |
| Q1 | Inhibitor of TNF-R and TLR signaling | immune evasion |
| C6 | Uncharacterized protein | unknown |
| C10 | Uncharacterized protein | unknown |
| F2 | Uncharacterized protein | unknown |
| G16 | Uncharacterized protein | unknown |
| A48 | Cu-Zn superoxide dismutase-like protein | others |
| G2 | dUTPase | others |
| H4 | Glutaredoxin-2 | others |
| A53 | DNA ligase | DNA replication |
| Rat-2 | ||
| B4 | EEV type-I membrane glycoprotein | membrane |
| A50 | Uncharacterized protein | unknown |
| A52 | Uncharacterized protein | unknown |
| B3 | Uncharacterized protein | unknown |
| C14 | Uncharacterized protein | unknown |
| B7 | IFN-γ receptor-like protein | immune evasion |
| Q1 | Inhibitor of TNF-R and TLR signaling | immune evasion |
| A53 | DNA ligase | DNA replication |
a According to UniProt; nomenclature CPXV GRI-90.
CPXV mature virion-associated host proteins that changed during passaging.
| Gene name | Description | Enrichment in OPV IMV a | Enrichment during Passaging b | ||||
|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | |||
| HEp-2 | |||||||
| PFN-1 | Profilin-1 | 35.1 | 1.3 | 0.5 | −0.1 | −0.6 | −1.1 |
| PGK1 | Phosphoglycerate kinase 1 | 12.9 | 1.2 | 0.6 | 0.2 | −1.3 | −0.6 |
| ARF1 | ADP-ribosylation factor 1 | 12.8 | 1.4 | 0.4 | −0.1 | −1.0 | −0.7 |
| PDCD6 | Programmed cell death protein 6 | 7.2 | 1.3 | 0.6 | −0.5 | −0.9 | −0.6 |
| XRCC5 | X-ray repair cross-complementing protein 5 | 6.6 | −1.1 | −0.6 | −0.2 | 0.5 | 1.4 |
| PRDX6 | Peroxiredoxin-6 | 4.3 | 1.5 | 0.4 | −0.1 | −1.0 | −0.8 |
| ATIC | Bifunctional purine biosynthesis protein | 3.7 | −1.2 | 0.1 | −0.8 | 0.9 | 0.9 |
| ACP1 | Acid phosphatase 1 | 3.3 | 1.2 | 0.6 | 0.1 | −1.1 | −0.8 |
| HSPA8 | Heat shock cognate 71 kDa protein | 2.4 | 1.0 | 0.5 | 0.6 | −1.3 | −0.7 |
| CAD | CAD protein | 2.4 | −1.8 | 0.3 | 0.4 | 0.4 | 0.7 |
| EIF3B | Eukaryotic translation initiation factor 3 subunit | 2.1 | −1.1 | −0.8 | 0.2 | 0.3 | 1.4 |
| MPG | DNA-3-methyladenine glycosylase | 2.0 | 1.2 | 0.5 | 0.0 | −1.2 | −0.6 |
| Rat-2 | |||||||
| Sqstm1 | Sequestosome-1 | 8.3 | 0.5 | 1.2 | 0.0 | −0.5 | −1.2 |
| Dstn | Destrin | 7.6 | 1.1 | −0.2 | 0.5 | 0.0 | −1.4 |
| Itpa | Inosine triphosphate pyrophosphatase | 4.6 | −1.4 | −0.2 | 0.5 | 0.7 | 0.5 |
| Phb2 | Prohibitin-2 | 3.4 | 1.0 | 0.9 | −0.6 | −0.3 | −1.0 |
| Psmc5 | 26S protease regulatory subunit 8 | 3.4 | −1.1 | −0.8 | 0.4 | 0.7 | 0.9 |
| Eif3b | Eukaryotic translation initiation factor 3 subunit B | 2.1 | −0.9 | −1.0 | 0.3 | 0.8 | 0.8 |
| Dnajc7 | DnaJ homolog subfamily C member 7 | 2.1 | 0.8 | 0.6 | −0.1 | 0.3 | −1.6 |
| Rab6a | Ras-related protein Rab-6A | 2.0 | 0.5 | 1.2 | −0.3 | −0.3 | −1.2 |
a iBAQ ratio OPV IMV to HepG2 ≥ 2 according to [30]; b Log2 (normalized LFQ); P1–P5: passage 1–5.